medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2019, Number 2

<< Back Next >>

Arch Med Fam 2019; 21 (2)

Therapeutic adherence in Polymedicated Patients and Conditioning Factors in a Group of Patients from Badajoz, Spain

Lorido CI, Hernanz AB, Cordero SE, González HA, Menaya MRG, Gómez EJ

Language: Spanish
References: 30
Page: 51-59
PDF size: 236.38 Kb.


ABSTRACT

Objective: To evaluate the level of therapeutic compliance and determining factors in polypharmacy patients aged over 65. Methods: observational, descriptive and cross-sectional study. Place: “El Progreso” Medical Centre in Badajoz, Spain. Polypharmacy patients older than 65 years with a consumption of 5 or more drugs, prescribed by electronic prescription. Data collection was performed since July 2016 until June 2017. From the 541 patients meeting the inclusion requirements, a random and representative sample of 90 patients was taken and calculated by a computer program called EPIDAT 3.1. This sample achieved a confidence interval of 95% with a recovery rate of 10%. 27 patients (30%) were excluded from the selected sample. Dependent variable: Morisky-Green test. Independent variables: age, sex, level of education, Gijon scale, control of drugs consumption, Barthel and Pfeiffer tests and pharmacological information, obtained from the digital medical record and personal interviews with the patients. It was carried out a descriptive analysis of --the variables. In order to compare the quantitative variables, we used the t of Student or the U of Mann Whitney and for the qualitative ones, the χ2 with the Yates´ correction or Fisher´s exact test. Results: 77.8% shows good compliance to the treatment. The only independent variable showing a statistically significant relation with the compliance of the treatment for the polypharmacy patients is the socio-familiar status (p=0.019). Conclusion: the patients living with their family increase the level of treatment compliance.


REFERENCES

  1. Villafaina A, Gavilán E. Pacientes polimedicados frágiles, un reto para el sistema sanitario Sistema Nacional de Salud. Ministerio de sanidad, servicios sociales e igualdad. 2011 Volumen 35, Nº4. Disponible en: http://www.msssi.gob.es/biblioPublic/publicaciones/recursos_propios/infMedic/docs/PolimedicadosVol35n4.pdf.

  2. Instituto nacional de estadística. España en cifras 2017. Disponible en: http://www.ine.es/prodyser/espa_cifras/2017/index.html#8.

  3. Sociedad Española de Medicina Interna (SEMI), Sociedad Española de Medicina de Familia y Comunitaria (semFYC) y Federación de Asociaciones de Enfermería Comunitaria y Atención Primaria (FAECAP). Desarrollo de guías de práctica clínica en paciente con comorbilidad y pluripatología; Abril 2013.

  4. Sabzwari SR, Qidwai W, Bhanji S. Polypharmacy in elderly: a cautious trail to tread. J Pak Med Assoc. 2013 May; 63(5):624-7.

  5. Novaes PH, da Cruz DT, Lucchetti ALG, Leite ICG, Lucchetti G. The "iatrogenic triad": polypharmacy, drugdrug interactions, and potentially inappropriate medications in older adults. Int J Clin Pharm. 2017 Aug; 39(4):818-825.

  6. Jouini S, Djebbi O, Souissi S, Bouhajja B. Iatrogenic adverse drug reaction in the emergency consultation of elderly people: epidemiological observational prospective study. Tunis Med. 2013 Mar; 91(3):200-4.

  7. Lee CS, Liew TM. Inappropriate prescribing among older persons in primary care: protocol for systematic review and meta-analysis of observational studies. BMJ Open. 2017 Feb 24;7(2):e015395.

  8. Dury R. Medication non-compliance in older patients: a multifactorial problem. Br J Community Nurs. 2013 Aug;18(8):383-5.

  9. Equipo de Atención Primaria. Análisis de la Situación de Salud de la Zona de Salud El Progreso. Centro de Salud El Progreso. Badajoz: Edita SES; 2007.

  10. Equipo de Atención Primaria. Análisis de la Situación de Salud de la Zona de Salud El Progreso. Centro de Salud El Progreso. Badajoz: Edita SES; 2014.

  11. Limaylla ML, Ramos NJ. Indirect methods of therapeutic compliance ratings. Ciencia e Investigación 2016; 19(2): 95-101.

  12. Badia X, Salamero M, Alonso J. La medida de la salud, guía de escalas de medición en español. Edimac. Barcelona 1999.

  13. Alvarez M. La importancia de la funcionalidad en la persona mayor. En: Grupo de Trabajo de la semFYC de Atención al Mayor. Atención a las Personas Mayores desde la Atención Primaria. semFYC ediciones. Barcelona 2004. Pags: 9-21.

  14. Martín-Lesende I. Escalas y pruebas de valoración funcional y cognitiva en el mayor. AMF 2013;9(9)508-514.

  15. Núñez AJ, Montiel A, Martín E, Torres B, Lara C, González JA. Adherencia al tratamiento en pacientes polimedicados mayores de 65 años con prescripción por principio activo. Aten Primaria. 2014; 46(5): 238-245.

  16. Tuesca-Molina R, Guallar-Castillón P, Banegas-Banegas JR, Graciani-Pérez RA. Determinantes del cumplimiento terapéutico en personas mayores de 60 años en España. Gac Sanit. 2006; 20(3): 220-7

  17. Park KA, Kim JG, Kim BW, Kam S, Kim KY, Ha SW, et al. Factors that Affect Medication Adherence in Elderly Patients with Diabetes Mellitus. Korean Diabetes J. 2010 Feb;34(1):55-65

  18. Lyles A, Culver N, Ivester J, Potter T. Effects of health literacy and polypharmacy on medication adherence. Consult Pharm. 2013 Dec; 28(12):793-9.

  19. Patton DE, Cadogan CA, Ryan C, Francis JJ, Gormley GJ, Passmore P, Kerse N, Hughes CM. Improving adherence to multiple medications in older people in primary care: Selecting intervention components to address patient-reported barriers and facilitators. Health Expect. 2018 Feb;21(1):138-148.

  20. Moral RR, Torres LA, Ortega LP, Larumbe MC, Villalobos AR, García JA, Rejano JM; Collaborative Group ATEM-AP Study. Effectiveness of motivational interviewing to improve therapeutic adherence in patients over 65 years old with chronic diseases: A cluster randomized clinical trial in primary care. Patient Educ Couns. 2015 Aug;98(8):977-83.

  21. Bosch-Lenders D, Maessen D, Stoffers H, Knottnerus JA, Van Den Akker M. Factors associated with appropriate knowledge of the indications for prescribed drugs among community-dwelling older patients with polypharmacy. Age and Ageing 2016; 0: 1–7 .

  22. Lyles A, Culver N, Ivester J, Potter T. Effects of Health Literacy and Polypharmacy on Medication Adherence. Consult Pharm 2013;28:793-9.

  23. Patton D, Cadogan CA, Ryan C, Francis JJ, GormleyGJ, Passmore P, Kerse N, Hughes CM. Improving adherence to multiple medications in older people in primary care: Selecting intervention components to address patient-reported barriers and facilitators. Health Expect. 2018 Feb; 21(1): 138–148.

  24. Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, Fagot-Campagna A, Penfornis A. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PLoS One. 2012;7(3):e32412.

  25. Moral J, Alejandra MT. Predictores psicosociales de adherencia a la medicación en pacientes con diabetes tipo 2. Revista Iberoamericana de Psicología y Salud 2015; 6: 19-27.

  26. Ortiz M, Ortiz E, Gatica A, Gómez D. Factores psicosociales asociados a la adherencia al tratamiento de la diabetes mellitus tipo 2. Terapia Psicológica. 2011; 29: 5-11.

  27. Díez-Nicolás J, Morenos-Páez M. La Soledad en España. Madrid: Fundación ONCE Y Fundación AXA; 2015.

  28. Holt-Lunstad J, Smith TB, Baker M, Loneliness and Social Isolation as Risk Factors for Mortality: A Meta- Analytic Review. First Published March 11, 2015. Disponible en: https://doi.org/10.1177/1745691614568352.

  29. Kar-Purkayastha I. An epidemic of loneliness. Lancet 2010; 376(9758):2114-2115.

  30. A, Vázquez M, García C, Matesanz A, Moreno E, Alguacil J, Camacho J. Análisis Urbanístico de barrios vulnerables. Madrid. 2009-2011. Disponible en: http://habitat.aq.upm.es/bbvv/bbvv_112.html.




2020     |     www.medigraphic.com